|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 113, Issue 12 2139-2147, Copyright © 2000 by Company of Biologists
JOURNAL ARTICLES |
X Yu, S Miyamoto and E Mekada
Institute of Life Science and Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Fukuoka 839-0861, Japan.
Certain integrins including alpha 2 beta 1 and alpha 3 beta 1 localize to intercellular binding sites, and thus may participate in cell-cell interactions. We demonstrated here the physical and functional associations of integrin alpha 2 beta 1 with epidermal growth factor receptor (EGFR) at intercellular adhesion sites. Immunoprecipitation with anti-integrin alpha 2 antibodies or anti-integrin beta 1 antibody resulted in preferential coprecipitation of EGFR from A431 cell lysates, while anti-EGFR antibody coprecipitated integrin alpha 2 beta 1. Chemical crosslinking confirmed the association of integrin alpha 2 beta 1 and EGFR. Colocalization of integrin alpha 2 beta 1 and EGFR at cell-cell contact sites was observed by double immunofluorescence staining of A431 cells. EGF-induced EGFR stimulation did not affect the association of integrin alpha 2 beta 1 and EGFR. However, immunostaining with the antibody specific to activated-EGFR revealed that EGFR localized at cell-cell contact sites are phosphorylated even in serum-depleted conditions, while EGFR localized to other sites is totally dephosphorylated in the same conditions. The EGFR phosphorylation in cell-cell contact sites observed in a serum-depleted culture was abrogated with a function-blocking antibody of integrin alpha 2, but not with a non-function-blocking alpha 2 antibody or function-blocking alpha 3 antibody. Moreover, the EGFR phosphorylation in serum-depleted conditions was not observed in suspended cells, or largely abrogated in sparse cells, indicating that cell-cell adhesion is required for EGFR phosphorylation. These results indicate that integrin alpha 2 beta 1 not only physically associates with EGFR but also functions in serum-independent EGFR activation at cell-cell contact sites. The present results shed a new light on the role of intercellular integrins in cell-cell interactions.
This article has been cited by other articles:
![]() |
S. C. Kirkland and H. Ying {alpha}2{beta}1 Integrin Regulates Lineage Commitment in Multipotent Human Colorectal Cancer Cells J. Biol. Chem., October 10, 2008; 283(41): 27612 - 27619. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yagi, F. Yotsumoto, and S. Miyamoto Heparin-binding epidermal growth factor-like growth factor promotes transcoelomic metastasis in ovarian cancer through epithelial-mesenchymal transition Mol. Cancer Ther., October 1, 2008; 7(10): 3441 - 3451. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Molli, L. Adam, and R. Kumar Therapeutic IMC-C225 Antibody Inhibits Breast Cancer Cell Invasiveness via Vav2-Dependent Activation of RhoA GTPase Clin. Cancer Res., October 1, 2008; 14(19): 6161 - 6170. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-Y. Lee, C.-Y. Chou, M.-J. Tang, and M.-R. Shen Epithelial-Mesenchymal Transition in Cervical Cancer: Correlation with Tumor Progression, Epidermal Growth Factor Receptor Overexpression, and Snail Up-Regulation Clin. Cancer Res., August 1, 2008; 14(15): 4743 - 4750. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ning, T. Buranda, and L. G. Hudson Activated Epidermal Growth Factor Receptor Induces Integrin {alpha}2 Internalization via Caveolae/Raft-dependent Endocytic Pathway J. Biol. Chem., March 2, 2007; 282(9): 6380 - 6387. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ning, R. Zeineldin, Y. Liu, M. Rosenberg, M. S. Stack, and L. G. Hudson Down-regulation of Integrin {alpha}2 Surface Expression by Mutant Epidermal Growth Factor Receptor (EGFRvIII) Induces Aberrant Cell Spreading and Focal Adhesion Formation Cancer Res., October 15, 2005; 65(20): 9280 - 9286. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Wang, F. Y. Wu, I. Shin, S. Qu, and C. L. Arteaga Transforming Growth Factor {beta} (TGF-{beta})-Smad Target Gene Protein Tyrosine Phosphatase Receptor Type Kappa Is Required for TGF-{beta} Function Mol. Cell. Biol., June 1, 2005; 25(11): 4703 - 4715. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Bill, B. Knudsen, S. L. Moores, S. K. Muthuswamy, V. R. Rao, J. S. Brugge, and C. K. Miranti Epidermal Growth Factor Receptor-Dependent Regulation of Integrin-Mediated Signaling and Cell Cycle Entry in Epithelial Cells Mol. Cell. Biol., October 1, 2004; 24(19): 8586 - 8599. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Pons, C. Peres, J.-M. Teulie, M. Nauze, M. Mus, C. Rolland, X. Collet, B. Perret, A. Gassama-Diagne, and F. Hullin-Matsuda Enterophilin-1 Interacts with Focal Adhesion Kinase and Decreases {beta}1 Integrins in Intestinal Caco-2 Cells J. Biol. Chem., March 5, 2004; 279(10): 9270 - 9277. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Q. Wang, P. Sun, and A. S. Paller Ganglioside GM3 Blocks the Activation of Epidermal Growth Factor Receptor Induced by Integrin at Specific Tyrosine Sites J. Biol. Chem., December 5, 2003; 278(49): 48770 - 48778. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Hobbs and F. M. Watt Regulation of Interleukin-1{alpha} Expression by Integrins and Epidermal Growth Factor Receptor in Keratinocytes from a Mouse Model of Inflammatory Skin Disease J. Biol. Chem., May 23, 2003; 278(22): 19798 - 19807. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Wang, X.-F. Zhang, and J. E. Groopman Stimulation of beta 1 Integrin Induces Tyrosine Phosphorylation of Vascular Endothelial Growth Factor Receptor-3 and Modulates Cell Migration J. Biol. Chem., November 2, 2001; 276(45): 41950 - 41957. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Yarwood and J. R. Woodgett Extracellular matrix composition determines the transcriptional response to epidermal growth factor receptor activation PNAS, April 10, 2001; 98(8): 4472 - 4477. [Abstract] [Full Text] [PDF] |
||||